Nautilus Biotechnology Inc

Market Cap

$348M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$2.39+$0.48 (+25.13%)

Jun 5, 2026

52W High $3.9552W Low $0.64

Company Details

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Plat...

CEO

—

IPO Date

Jun 10, 2021

Website

www.nautilus.bio

Key Metrics TTM

Revenue

-100.0% YoY

Net Income

-$57M

EPS (Diluted)

Free Cash Flow

-$51M

Revenue / Share

$0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

Q2 2026

Jul 30, 2026

PENDING

Q1 2026

Apr 28, 2026

FY 2025

Feb 26, 2026

Q4 2025

Feb 26, 2026

$0-100.0%

Q3 2025

Oct 28, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee